tbuckley/cabot-search huggingface dataset:
Genetic Polymorphisms and Sunitinib Toxicity in Metastatic Renal-Cell Carcinoma
Authors: J. Sepulveda Sanchez, C. Farfan, F. Villacampa, G. Velasco, J. Benitez, C. Rodriguez, M. Calderon, I. Cañamares, H. Cortes-Funes, D.E. Castellano
Journal: Annals of Oncology (2012)
Safety of Abiraterone Acetate (AA) in Patients with Castration Resistant Prostate Cancer (CRPC) and Concomitant Cardiac Risk
Authors: G. Procopio, E. Verzoni, I. Testa, S. Stagni, S. Villa, R. Valdagni, F.G.M. De Braud
Journal: Annals of Oncology (2012)
Circulating Tumor Cells (CTCS) in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC): Frequency, Clinical Significance and EGFR Expression
Authors: S. Grisanti, C. Almici, F. Consoli, R. Verardi, M. Buglione, V.D. Ferrari, A. Bolzoni-Villaret, P. Nicolai, S.M. Magrini, E. Simoncini
Journal: Annals of Oncology (2012)
AMG-176, an Mcl-1 Antagonist, Shows Preclinical Efficacy in Chronic Lymphocytic Leukemia
Authors: Xue Yi, Aloke Sarkar, Gorkem Kismali, Burcu Aslan, Mary Ayres, LaKesla R. Iles, Michael J. Keating, William G. Wierda, James P. Long, Maria Teresa Sabrina Bertilaccio, Varsha Gandhi
Journal: Clinical Cancer Research (2020)

Abstract Purpose: Survival of CLL cells due to the presence of Bcl-2 and Mcl-1 has been established. Direct inhibition of Bcl-2 by venetoclax and indirect targeting of Mcl-1 with transcription inhibitors have been successful approaches for CLL. AMG-176 is a selective and direct antagonist of Mcl-1, which has shown efficacy in several hematologic malignancies; however, its effect on CLL is elusive. We evaluated biological and molecular effects of AMG-176 in primary CLL cells. Experimental Design: Using samples from patients (n = 74) with CLL, we tested effects of AMG-176 on CLL and normal hematopoietic cell death and compared importance of CLL prognostic factors on this biological activity. We evaluated CLL cell apoptosis in the presence of stromal cells and identified cell death pathway including stabilization of Mcl-1 protein. Finally, we tested a couplet of AMG-176 and venetoclax in CLL lymphocytes. Results: AMG-176 incubations resulted in time- and dose-dependent CLL cell death. At 100 and 300 nmol/L, there was 30% and 45% cell death at 24 hours. These concentrations did not result in significant cell death in normal hematopoietic cells. Presence of stroma did not affect AMG-176–induced CLL cell death. IGHV unmutated status, high β2M and Mcl-1 protein levels resulted in slightly lower cell death. Mcl-1, but not Bcl-2 protein levels, in CLL cells increased with AMG-176. Low concentrations of venetoclax (1–30 nmol/L) were additive or synergistic with AMG-176. Conclusions: AMG-176 is active in inducing CLL cell death while sparing normal blood cells. Combination with low-dose venetoclax was additive or synergistic.
New business models for research and development with affordability requirements are needed to achieve fair pricing of medicines
Authors: Fatima Suleman, Marcus Low, Suerie Moon, Steven G Morgan
Journal: BMJ (2020)

For research and development to systematically deliver fairly priced medicines, new approaches to financing and organisation are needed, and affordability must be integrated into push, pull, and pooling mechanisms, say <b>Fatima Suleman and colleagues</b>
Sunitinib Global Expanded-Access Trial in Metastatic Renal Cell Carcinoma (MRCC) – Final Results
Authors: M.E. Gore, C. Porta, S. Bracarda, G.A. Bjarnason, S. Oudard, S. Lee, L. Crino, T.M. Kim, K. Fly, C. Szczylik
Journal: Annals of Oncology (2012)
Cost of Treatment of Acute Myeloid Leukemia – Experiences from a Developing Country
Authors: D. Arya, B. Parikh, P.M. Shah, K.M. Patel, S.N. Shukla, A.S. Anand, S.S. Talati, S.A. Shah, A.A. Patel, B.B. Parekh
Journal: Annals of Oncology (2012)
Cytogenetic analysis of Circulating Tumor Cells of metastatic prostate cancer
Authors: Arjan Tibbe, Joost Swenenhuis, Rianne Levink, Ronald Sipkema, Leon Terstappen
Journal: Cancer Research (2008)

2174  Tumor cells in blood of patients with metastatic carcinomas have been associated with poor survival prospects. In this study we evaluate the presence of cytogenetic abnormalities in Circulating Tumor Cells (CTC) detected in patients with metastatic prostate cancer. CTCs were enumerated in 7.5 mL of blood with the CellSearch System. After enumeration of the Cytokeratin+, CD45-, nucleated CTC, the fluid in the analysis cartridge was removed and the cells were fixed while maintaining their original position. Fluorescence in situ hybridization (FISH) is applied to the fixed cells labeling the centromeric regions of chromosome 1, 7, 8 and 17. After FISH the cartridges were placed on a CellTracks Analyzer equipped with a 40X objective (NA0.60). The previous identified CTCs are revisited and fluorescent images of each of the four chromosomes labels were acquired. Next, the copy number of chromosomes 1, 7, 8 and 17 were determined for each CTC. Leukocytes surrounding the CTC were used as internal controls. 61% of the blood samples taken after initiation of therapy contained ≥ 1 CTCs and FISH was applied to 84 of the CTC containing blood samples from 42 metastatic prostate cancer patients. The 84 samples contained a total of 2932 CTC (mean=5, average= 33.7, SD=76.0). Of the 2932 CTC, 225 (8%) were lost during the fixation and FISH. Of the remaining 2707 CTC no FISH signals were detected in 69% of the CTC. The lack of FISH signals in these CTC is ascribed to apoptosis as the surrounding leukocytes showed good quality FISH signals. The 829 (31%) evaluable CTC contained on average 2.8 copies of chromosome 1, 3.0 copies of chromosome 7, 3.3 copies of chromosome 8 and 2.3 copies of chromosome 17. 664/829 (80%) of the CTC were aneuploid and a higher amplification of the chromosomes 1, 7, 8 and 17 was observed with increasing CTC number. In only 1 patient no aneuploid cells were detected and this patient only had 1 CTC. Heterogeneity in the chromosomal abnormalities was observed between CTC of different patients as well as among CTC of the same patient. In the same samples 885 leukocytes were evaluated as controls and showed an average of 1.9, 2.0, 1.9 and 1.8 copies of chromosome 1, 7, 8 and 17 respectively. Cytogenetic composition of CTC can be assessed after they have been identified by the CellSearch system. The relation between the presence of aneusomy, the extent of amplification and outcome will next be investigated.
Final Analysis of Randomized Phase II Trial of Carboplatin Combined with Weekly Paclitaxel (CP) and Docetaxel Alone (D) in Elderly Patients (PTS) with Advanced Non-Small Cell Lung Cancer (NSCLC): NJLCG 0801
Authors: T. Harada, M. Maemondo, S. Sugawara, A. Inoue, K. Usui, M. Ando, N. Morikawa, Y. Mori, A. Gemma, T. Nukiwa
Journal: Annals of Oncology (2012)
Breast Cancer (BC) and the Study of Intratumoral Heterogeneity through PI3K Pathway-Biomarkers
Authors: L. De Mattos-Arruda, J. Cortes, C.M. Aura, J. Gregori, G. Caratú, C. Saura, M. Oliveira, J. Tabernero, J. Seoane, A. Vivancos
Journal: Annals of Oncology (2012)
Extrapolation Pitfalls and Methodology Flaws in Curing Anemia via Parental Education and Counseling
Authors: Bo Zhou, Wenquan Niu
Journal: JAMA Pediatrics (2020)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Pediatrics HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Pediatrics journal
Endoscopic sleeve gastroplasty in the management of weight regain after sleeve gastrectomy
Authors: Diogo Turiani Hourneaux de Moura, Sérgio Barrichello Jr, Eduardo Guimarães Hourneaux de Moura, Thiago Ferreira de Souza, Manoel dos Passos Galvão Neto, Eduardo Grecco, Bruno Sander, Anna Carolina Hoff, Felipe Matz, Flávio Ramos, João Henrique Felício de Lima, Leonardo Teixeira, Victor Dib, Marcelo Falcão, Helmut Potti, Giorgio Baretta, Pichamol Jirapinyo, Christopher C. Thompson
Journal: Endoscopy (2020)

Abstract Background Sleeve gastrectomy is a well-standardized surgical treatment for obesity. However, rates of weight regain after sleeve gastrectomy in long-term follow-up are relatively high. This multicenter study is the first to evaluate the use of an endoscopic sleeve gastroplasty (ESG) technique for the management of this population. Methods This was a multicenter retrospective study, including patients with weight regain following sleeve gastrectomy who underwent ESG for weight loss. Primary outcomes included absolute weight loss, percent total weight loss (%TWL), change in body mass index (BMI), percent excess weight loss (%EWL) at 6 and 12 months, and safety profile. Clinical success was defined as achieving ≥ 25 % EWL at 1 year, ≤ 5 % serious adverse event (SAE) rate following society-recommended thresholds, and %TWL ≥ 10 %. Results 34 patients underwent ESG after sleeve gastrectomy. Technical success was 100 %. At 1 year, 82.4 % and 100 % of patients achieved ≥ 10 %TWL and ≥ 25 % EWL, respectively. Mean (SD) %TWL was 13.2 % (3.9) and 18.3 % (5.5), and %EWL was 51.9 % (19.1) and 69.9 % (29.9) at 6 months and 1 year, respectively. Mean (SD) %TWL was 14.2 % (12.5), 19.3 % (5.3), 17.5 % (5.2), and 20.4 % (3.3), and %EWL was 88.5 % (52.8), 84.4 % (22.4), 55.4 % (14.8), and 47.8 % (11.2) for BMI categories of overweight and obesity class I, II, and III, respectively, at 1 year. No predictors of success were identified in the multivariable regression analysis. No SAEs were reported. Conclusion ESG appears to be safe and effective in the management of weight regain following sleeve gastrectomy.
First Rites—A Spiritual History Case Study
Authors: Alex Herbert Lion
Journal: JAMA Oncology (2020)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Oncology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Oncology journal
Predictive Value of Two Phenotyping Probes for the Pharmacokinetics of Sunitinib in Cancer Patients
Authors: J.S.L. Kloth, H.J. Klumpen, C.F. Samer, K. Eechoute, N.A.G. Lankheet, B.L. Kam, M. Wong, J.H.M. Schellens, R.H.J. Mathijssen, H. Gurney
Journal: Annals of Oncology (2012)
Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives
Authors: Yuan Fang, Guochao Liao, Bin Yu
Journal: Acta Pharmaceutica Sinica B (2020)

Blocking the MDM2/X–P53 protein–protein interaction has been widely recognized as an attractive therapeutic strategy for the treatment of cancers. Numerous small-molecule MDM2 inhibitors have been reported since the release of the structure of the MDM2–P53 interaction in 1996, SAR405838, NVP-CGM097, MK-8242, RG7112, RG7388, DS-3032b, and AMG232 currently undergo clinical evaluation for cancer therapy. This review is intended to provide a comprehensive and updated overview of MDM2 inhibitors and proteolysis targeting chimera (PROTAC) degraders with a particular focus on how these inhibitors or degraders are identified from starting points, strategies employed, structure–activity relationship (SAR) studies, binding modes or co-crystal structures, biochemical data, mechanistic studies, and preclinical/clinical studies. Moreover, we briefly discuss the challenges of designing MDM2/X inhibitors for cancer therapy such as dual MDM2/X inhibition, acquired resistance and toxicity of P53 activation as well as future directions.
A Phase 3 Study to Evaluate the Efficacy and Safety of Docetaxel and Prednisone (DP) with or without Lenalidomide (LEN) in Patients with Castrate-Resistant Prostate Cancer (CRPC): The Mainsail Trial
Authors: D.P. Petrylak, K. Fizazi, C.N. Sternberg, N. Budnik, R. De Wit, P.J. Wiechno, J. Bellmunt, D. Barton, A. Fandi, U. Jungnelius, S. Li, N. Vogelzang
Journal: Annals of Oncology (2012)
Peritumoral Vascular Invasion as Principal Istological Prognostic Factor in TNBC
Authors: G. Rizzo, V. Fregoni, G. Daprada, L. Pavesi, G. Gallizzi, I.T. Lorenzetti, R. Tancredi, E. Ferraris, A. Pagani
Journal: Annals of Oncology (2012)
The Role of Macrophages Polarization in Predicting Prognosis in Radically Resected Gastric Cancer
Authors: F. Pantano, P. Berti, F.M. Guida, S. Intagliata, F. Graziano, G. Perrone, A. Onetti Muda, B. Vincenzi, G. Tonini, D. Santini
Journal: Annals of Oncology (2012)
Bone Turnover Markers and Potential Correlation with Outcomes in Patients with Genitourinary Cancer (PROSTATE) and Bone Metastasis (RESULTS OF TUGAMO STUDY)
Authors: J. Bellmunt, C.La De Piedra, A. Gómez Caamaño, M.J. Ribal, F. Vázquez, U. Anido, E. Solsona, P. Samper, E. Esteban, J. Morote
Journal: Annals of Oncology (2012)
A Randomised Phase II Study of Carboplatin and Bevacizumab in Recurrent Glioblastoma Multiforme (CABARET STUDY). Cooperative Trials Group For Neuro-Oncology (COGNO)
Authors: K. Field, M.A. Rosenthal, H. Wheeler, L. Cher, E. Hovey, A.K. Nowak, C. Brown, A. Livingstone, K. Sawkins, R.J. Simes
Journal: Annals of Oncology (2012)
Liver‐on‐a‐Chip Models of Fatty Liver Disease
Authors: Shabir Hassan, Shikha Sebastian, Sushila Maharjan, Ami Lesha, Anne‐Marie Carpenter, Xiuli Liu, Xin Xie, Carol Livermore, Yu Shrike Zhang, Ali Zarrinpar
Journal: Hepatology (2020)

Hassan, Shabir; Sebastian, Shikha; Maharjan, Sushila; Lesha, Ami; Carpenter, Anne‐Marie; Liu, Xiuli; Xie, Xin; Livermore, Carol; Zhang, Yu Shrike; Zarrinpar, Ali Author Information
Myeloid-Derived Suppressor Cells are Increased and Correlated with Type 2 Immune Responses in Breast Cancer Patients
Authors: K. Gonda, M. Shibata, T. Ohtake, T. Shimura, K. Sakurai, T. Machida, H. Outo, S. Takenoshita
Journal: Annals of Oncology (2012)
One’s Self I Sing Too
Authors: Shane Neilson
Journal: JAMA (2020)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
P-0250 A New Staging System in Colorectal Cancer (CRC) Limited to the Liver: A Retrospective Review
Authors: Lourdes Calera, Fernando Rivera, Isabel Pajares, Carmen Vallejo, Ana Cebollero, Alba Hernandez, Itxiar Trueba, Lourdes Gutierrez, Raquel Jaso, Antonio Anton
Journal: Annals of Oncology (2012)
Is There an Association Between Social Media Use and Mental Health? The Timing of Confounding Measurement Matters—Reply
Authors: Kenneth A. Feder, Kira E. Riehm, Ramin Mojtabai
Journal: JAMA Psychiatry (2020)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Psychiatry HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Psychiatry journal
Pancreatic triglyceride lipase mediates lipotoxic systemic inflammation
Authors: Cristiane de Oliveira, Biswajit Khatua, Pawan Noel, Sergiy Kostenko, Arup Bag, Bijinu Balakrishnan, Krutika S. Patel, Andre A. Guerra, Melissa N. Martinez, Shubham Trivedi, Ann McCullough, Dora M. Lam-Himlin, Sarah Navina, Douglas O. Faigel, Norio Fukami, Rahul Pannala, Anna Evans Phillips, Georgios I. Papachristou, Erin E. Kershaw, Mark E. Lowe, Vijay P. Singh
Journal: Journal of Clinical Investigation (2020)

Visceral adipose tissue plays a critical role in numerous diseases. Although imaging studies often show adipose involvement in abdominal diseases, their outcomes may vary from being a mild self-limited illness to one with systemic inflammation and organ failure. We therefore compared the pattern of visceral adipose injury during acute pancreatitis and acute diverticulitis to determine its role in organ failure. Acute pancreatitis–associated adipose tissue had ongoing lipolysis in the absence of adipocyte triglyceride lipase (ATGL). Pancreatic lipase injected into mouse visceral adipose tissue hydrolyzed adipose triglyceride and generated excess nonesterified fatty acids (NEFAs), which caused organ failure in the absence of acute pancreatitis. Pancreatic triglyceride lipase (PNLIP) increased in adipose tissue during pancreatitis and entered adipocytes by multiple mechanisms, hydrolyzing adipose triglyceride and generating excess NEFAs. During pancreatitis, obese PNLIP-knockout mice, unlike obese adipocyte-specific ATGL knockouts, had lower visceral adipose tissue lipolysis, milder inflammation, less severe organ failure, and improved survival. PNLIP-knockout mice, unlike ATGL knockouts, were protected from adipocyte-induced pancreatic acinar injury without affecting NEFA signaling or acute pancreatitis induction. Therefore, during pancreatitis, unlike diverticulitis, PNLIP leaking into visceral adipose tissue can cause excessive visceral adipose tissue lipolysis independently of adipocyte-autonomous ATGL, and thereby worsen organ failure.
High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?
Authors: Priyanka A. Pophali, Lisa M. Marinelli, Rhett P. Ketterling, Reid G. Meyer, Ellen D. McPhail, Paul J. Kurtin, Raphael Mwangi, Matthew J. Maurer, Thomas Habermann, Rebecca L. King
Journal: Blood Cancer Journal (2020)

While MYC translocations in B-cell lymphoma (BCL) have been extensively studied, the significance of MYC amplification (MYC amp) is poorly understood. This study characterizes BCL showing MYC amp, defined as uncountable FISH signals. Retrospective analysis of all BCL FISH for MYC aberrations performed at our institution (1/2010-2/2018) identified 44/9715 (0.45%) cases with MYC amp. MYC amp probe signals appeared in a cloud-like distribution (70%) or in a single homogenous-staining-region (30%). In total 59% also had MYC separation by breakapart probe indicating concurrent MYC translocation. The most common morphology was large cell (82%) and diagnosis was diffuse large BCL (DLBCL, 50%). In total 88% were germinal center B-cell-like by Hans algorithm. In total 12/42 (29%) cases were "double-hit" by WHO criteria (DHL/THL) in addition to having MYC amp. The estimated 2-year overall survival (OS) of DLBCL cases with MYC amp was 80%. There was no significant difference in OS between DLBCL and DHL/THL among cases with MYC amp, suggesting a poor prognostic impact of MYC amp. However, when compared to a larger cohort of DLBCL and DHL/THL, MYC amp did not have prognostic significance. In summary, MYC amp in BCL is rare, most commonly occurs in DLBCL, and was not associated with survival in our cohort.
Stromal Cell-Derived Factor-1α is Associated with Gallbladder Carcinoma Progression and is a Novel Independent Poor Prognostic Factor
Authors: H.J. Lee, J.-K. Min, H.J. Lee, K. Lee, D.G. Lee, Z.L. Liang, S.M. Huang, Y.S. Oh, H.Y. Kim, D.Y. Jo, J.-M. Kim
Journal: Annals of Oncology (2012)